ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biopharmaceuticals for Psoriasis Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-13L17649
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharmaceuticals for Psoriasis Market Research Report 2024
BUY CHAPTERS

Global Biopharmaceuticals for Psoriasis Market Research Report 2024

Code: QYRE-Auto-13L17649
Report
July 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Eli Lilly
Johnson & Johnson
Pfizer Inc
AbbVie
Organon
UCB

Biopharmaceuticals for Psoriasis Market

Psoriasis is a common chronic inflammatory skin disease characterized by excessive proliferation of skin cells, resulting in thick, red patches covered with silvery-white scales on the skin surface. The cause of psoriasis is not fully understood, but it is believed to be related to abnormalities in the immune system, especially excessive activity of T cells in the skin. Genetic factors and environmental factors (such as infection, stress, skin damage and certain drugs) may also induce or aggravate the disease.
The global Biopharmaceuticals for Psoriasis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Biopharmaceuticals for Psoriasis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biopharmaceuticals for Psoriasis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Biopharmaceuticals for Psoriasis include Amgen, Eli Lilly, Johnson & Johnson, Pfizer, AbbVie, Organon, UCB, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals for Psoriasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals for Psoriasis.
The Biopharmaceuticals for Psoriasis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Biopharmaceuticals for Psoriasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceuticals for Psoriasis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biopharmaceuticals for Psoriasis Market Report

Report Metric Details
Report Name Biopharmaceuticals for Psoriasis Market
Segment by Type
  • TNF-α
  • Interleukin-17
  • Interleukin-23
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, Eli Lilly, Johnson & Johnson, Pfizer, AbbVie, Organon, UCB
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Biopharmaceuticals for Psoriasis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Biopharmaceuticals for Psoriasis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Biopharmaceuticals for Psoriasis Market report?

Ans: The main players in the Biopharmaceuticals for Psoriasis Market are Amgen, Eli Lilly, Johnson & Johnson, Pfizer, AbbVie, Organon, UCB

What are the Application segmentation covered in the Biopharmaceuticals for Psoriasis Market report?

Ans: The Applications covered in the Biopharmaceuticals for Psoriasis Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Biopharmaceuticals for Psoriasis Market report?

Ans: The Types covered in the Biopharmaceuticals for Psoriasis Market report are TNF-α, Interleukin-17, Interleukin-23, Other

1 Biopharmaceuticals for Psoriasis Market Overview
1.1 Product Definition
1.2 Biopharmaceuticals for Psoriasis by Type
1.2.1 Global Biopharmaceuticals for Psoriasis Market Value Comparison by Type (2024-2030)
1.2.2 TNF-α
1.2.3 Interleukin-17
1.2.4 Interleukin-23
1.2.5 Other
1.3 Biopharmaceuticals for Psoriasis by Application
1.3.1 Global Biopharmaceuticals for Psoriasis Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Biopharmaceuticals for Psoriasis Market Size Estimates and Forecasts
1.4.1 Global Biopharmaceuticals for Psoriasis Revenue 2019-2030
1.4.2 Global Biopharmaceuticals for Psoriasis Sales 2019-2030
1.4.3 Global Biopharmaceuticals for Psoriasis Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biopharmaceuticals for Psoriasis Market Competition by Manufacturers
2.1 Global Biopharmaceuticals for Psoriasis Sales Market Share by Manufacturers (2019-2024)
2.2 Global Biopharmaceuticals for Psoriasis Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Biopharmaceuticals for Psoriasis Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Biopharmaceuticals for Psoriasis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Product Type & Application
2.7 Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Date of Enter into This Industry
2.8 Global Biopharmaceuticals for Psoriasis Market Competitive Situation and Trends
2.8.1 Global Biopharmaceuticals for Psoriasis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biopharmaceuticals for Psoriasis Players Market Share by Revenue
2.8.3 Global Biopharmaceuticals for Psoriasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biopharmaceuticals for Psoriasis Market Scenario by Region
3.1 Global Biopharmaceuticals for Psoriasis Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biopharmaceuticals for Psoriasis Sales by Region: 2019-2030
3.2.1 Global Biopharmaceuticals for Psoriasis Sales by Region: 2019-2024
3.2.2 Global Biopharmaceuticals for Psoriasis Sales by Region: 2025-2030
3.3 Global Biopharmaceuticals for Psoriasis Revenue by Region: 2019-2030
3.3.1 Global Biopharmaceuticals for Psoriasis Revenue by Region: 2019-2024
3.3.2 Global Biopharmaceuticals for Psoriasis Revenue by Region: 2025-2030
3.4 North America Biopharmaceuticals for Psoriasis Market Facts & Figures by Country
3.4.1 North America Biopharmaceuticals for Psoriasis Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biopharmaceuticals for Psoriasis Sales by Country (2019-2030)
3.4.3 North America Biopharmaceuticals for Psoriasis Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biopharmaceuticals for Psoriasis Market Facts & Figures by Country
3.5.1 Europe Biopharmaceuticals for Psoriasis Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biopharmaceuticals for Psoriasis Sales by Country (2019-2030)
3.5.3 Europe Biopharmaceuticals for Psoriasis Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biopharmaceuticals for Psoriasis Market Facts & Figures by Region
3.6.1 Asia Pacific Biopharmaceuticals for Psoriasis Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biopharmaceuticals for Psoriasis Sales by Region (2019-2030)
3.6.3 Asia Pacific Biopharmaceuticals for Psoriasis Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biopharmaceuticals for Psoriasis Market Facts & Figures by Country
3.7.1 Latin America Biopharmaceuticals for Psoriasis Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biopharmaceuticals for Psoriasis Sales by Country (2019-2030)
3.7.3 Latin America Biopharmaceuticals for Psoriasis Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Biopharmaceuticals for Psoriasis Market Facts & Figures by Country
3.8.1 Middle East and Africa Biopharmaceuticals for Psoriasis Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biopharmaceuticals for Psoriasis Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biopharmaceuticals for Psoriasis Sales by Type (2019-2030)
4.1.1 Global Biopharmaceuticals for Psoriasis Sales by Type (2019-2024)
4.1.2 Global Biopharmaceuticals for Psoriasis Sales by Type (2025-2030)
4.1.3 Global Biopharmaceuticals for Psoriasis Sales Market Share by Type (2019-2030)
4.2 Global Biopharmaceuticals for Psoriasis Revenue by Type (2019-2030)
4.2.1 Global Biopharmaceuticals for Psoriasis Revenue by Type (2019-2024)
4.2.2 Global Biopharmaceuticals for Psoriasis Revenue by Type (2025-2030)
4.2.3 Global Biopharmaceuticals for Psoriasis Revenue Market Share by Type (2019-2030)
4.3 Global Biopharmaceuticals for Psoriasis Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biopharmaceuticals for Psoriasis Sales by Application (2019-2030)
5.1.1 Global Biopharmaceuticals for Psoriasis Sales by Application (2019-2024)
5.1.2 Global Biopharmaceuticals for Psoriasis Sales by Application (2025-2030)
5.1.3 Global Biopharmaceuticals for Psoriasis Sales Market Share by Application (2019-2030)
5.2 Global Biopharmaceuticals for Psoriasis Revenue by Application (2019-2030)
5.2.1 Global Biopharmaceuticals for Psoriasis Revenue by Application (2019-2024)
5.2.2 Global Biopharmaceuticals for Psoriasis Revenue by Application (2025-2030)
5.2.3 Global Biopharmaceuticals for Psoriasis Revenue Market Share by Application (2019-2030)
5.3 Global Biopharmaceuticals for Psoriasis Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Biopharmaceuticals for Psoriasis Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly Biopharmaceuticals for Psoriasis Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Biopharmaceuticals for Psoriasis Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Biopharmaceuticals for Psoriasis Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Company Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie Biopharmaceuticals for Psoriasis Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Organon
6.6.1 Organon Company Information
6.6.2 Organon Description and Business Overview
6.6.3 Organon Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Organon Biopharmaceuticals for Psoriasis Product Portfolio
6.6.5 Organon Recent Developments/Updates
6.7 UCB
6.7.1 UCB Company Information
6.7.2 UCB Description and Business Overview
6.7.3 UCB Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2019-2024)
6.7.4 UCB Biopharmaceuticals for Psoriasis Product Portfolio
6.7.5 UCB Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biopharmaceuticals for Psoriasis Industry Chain Analysis
7.2 Biopharmaceuticals for Psoriasis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biopharmaceuticals for Psoriasis Production Mode & Process
7.4 Biopharmaceuticals for Psoriasis Sales and Marketing
7.4.1 Biopharmaceuticals for Psoriasis Sales Channels
7.4.2 Biopharmaceuticals for Psoriasis Distributors
7.5 Biopharmaceuticals for Psoriasis Customers
8 Biopharmaceuticals for Psoriasis Market Dynamics
8.1 Biopharmaceuticals for Psoriasis Industry Trends
8.2 Biopharmaceuticals for Psoriasis Market Drivers
8.3 Biopharmaceuticals for Psoriasis Market Challenges
8.4 Biopharmaceuticals for Psoriasis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amgen Inc
Eli Lilly
Johnson & Johnson
Pfizer Inc
AbbVie
Organon
UCB
List of Tables
 Table 1. Global Biopharmaceuticals for Psoriasis Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Biopharmaceuticals for Psoriasis Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Biopharmaceuticals for Psoriasis Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Biopharmaceuticals for Psoriasis Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Biopharmaceuticals for Psoriasis Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Biopharmaceuticals for Psoriasis Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Biopharmaceuticals for Psoriasis Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Biopharmaceuticals for Psoriasis Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Biopharmaceuticals for Psoriasis, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Product Type & Application
 Table 12. Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biopharmaceuticals for Psoriasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceuticals for Psoriasis as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biopharmaceuticals for Psoriasis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Biopharmaceuticals for Psoriasis Sales by Region (2019-2024) & (K Units)
 Table 18. Global Biopharmaceuticals for Psoriasis Sales Market Share by Region (2019-2024)
 Table 19. Global Biopharmaceuticals for Psoriasis Sales by Region (2025-2030) & (K Units)
 Table 20. Global Biopharmaceuticals for Psoriasis Sales Market Share by Region (2025-2030)
 Table 21. Global Biopharmaceuticals for Psoriasis Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Region (2019-2024)
 Table 23. Global Biopharmaceuticals for Psoriasis Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Region (2025-2030)
 Table 25. North America Biopharmaceuticals for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Biopharmaceuticals for Psoriasis Sales by Country (2019-2024) & (K Units)
 Table 27. North America Biopharmaceuticals for Psoriasis Sales by Country (2025-2030) & (K Units)
 Table 28. North America Biopharmaceuticals for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Biopharmaceuticals for Psoriasis Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Biopharmaceuticals for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Biopharmaceuticals for Psoriasis Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Biopharmaceuticals for Psoriasis Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Biopharmaceuticals for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Biopharmaceuticals for Psoriasis Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Biopharmaceuticals for Psoriasis Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Biopharmaceuticals for Psoriasis Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Biopharmaceuticals for Psoriasis Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Biopharmaceuticals for Psoriasis Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Biopharmaceuticals for Psoriasis Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Biopharmaceuticals for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Biopharmaceuticals for Psoriasis Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Biopharmaceuticals for Psoriasis Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Biopharmaceuticals for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Biopharmaceuticals for Psoriasis Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Biopharmaceuticals for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Biopharmaceuticals for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Biopharmaceuticals for Psoriasis Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Biopharmaceuticals for Psoriasis Sales (K Units) by Type (2019-2024)
 Table 51. Global Biopharmaceuticals for Psoriasis Sales (K Units) by Type (2025-2030)
 Table 52. Global Biopharmaceuticals for Psoriasis Sales Market Share by Type (2019-2024)
 Table 53. Global Biopharmaceuticals for Psoriasis Sales Market Share by Type (2025-2030)
 Table 54. Global Biopharmaceuticals for Psoriasis Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Biopharmaceuticals for Psoriasis Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Type (2019-2024)
 Table 57. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Type (2025-2030)
 Table 58. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Biopharmaceuticals for Psoriasis Sales (K Units) by Application (2019-2024)
 Table 61. Global Biopharmaceuticals for Psoriasis Sales (K Units) by Application (2025-2030)
 Table 62. Global Biopharmaceuticals for Psoriasis Sales Market Share by Application (2019-2024)
 Table 63. Global Biopharmaceuticals for Psoriasis Sales Market Share by Application (2025-2030)
 Table 64. Global Biopharmaceuticals for Psoriasis Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Biopharmaceuticals for Psoriasis Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Application (2019-2024)
 Table 67. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Application (2025-2030)
 Table 68. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Application (2025-2030)
 Table 70. Amgen Company Information
 Table 71. Amgen Description and Business Overview
 Table 72. Amgen Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Amgen Biopharmaceuticals for Psoriasis Product
 Table 74. Amgen Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Eli Lilly Biopharmaceuticals for Psoriasis Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Johnson & Johnson Biopharmaceuticals for Psoriasis Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Pfizer Biopharmaceuticals for Psoriasis Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. AbbVie Company Information
 Table 91. AbbVie Description and Business Overview
 Table 92. AbbVie Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. AbbVie Biopharmaceuticals for Psoriasis Product
 Table 94. AbbVie Recent Developments/Updates
 Table 95. Organon Company Information
 Table 96. Organon Description and Business Overview
 Table 97. Organon Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Organon Biopharmaceuticals for Psoriasis Product
 Table 99. Organon Recent Developments/Updates
 Table 100. UCB Company Information
 Table 101. UCB Description and Business Overview
 Table 102. UCB Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. UCB Biopharmaceuticals for Psoriasis Product
 Table 104. UCB Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Biopharmaceuticals for Psoriasis Distributors List
 Table 108. Biopharmaceuticals for Psoriasis Customers List
 Table 109. Biopharmaceuticals for Psoriasis Market Trends
 Table 110. Biopharmaceuticals for Psoriasis Market Drivers
 Table 111. Biopharmaceuticals for Psoriasis Market Challenges
 Table 112. Biopharmaceuticals for Psoriasis Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biopharmaceuticals for Psoriasis
 Figure 2. Global Biopharmaceuticals for Psoriasis Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Biopharmaceuticals for Psoriasis Market Share by Type: 2023 & 2030
 Figure 4. TNF-α Product Picture
 Figure 5. Interleukin-17 Product Picture
 Figure 6. Interleukin-23 Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Biopharmaceuticals for Psoriasis Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Biopharmaceuticals for Psoriasis Market Share by Application: 2023 & 2030
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Other
 Figure 13. Global Biopharmaceuticals for Psoriasis Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Biopharmaceuticals for Psoriasis Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Biopharmaceuticals for Psoriasis Sales (2019-2030) & (K Units)
 Figure 16. Global Biopharmaceuticals for Psoriasis Average Price (US$/Unit) & (2019-2030)
 Figure 17. Biopharmaceuticals for Psoriasis Report Years Considered
 Figure 18. Biopharmaceuticals for Psoriasis Sales Share by Manufacturers in 2023
 Figure 19. Global Biopharmaceuticals for Psoriasis Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Biopharmaceuticals for Psoriasis Players: Market Share by Revenue in Biopharmaceuticals for Psoriasis in 2023
 Figure 21. Biopharmaceuticals for Psoriasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Biopharmaceuticals for Psoriasis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Biopharmaceuticals for Psoriasis Sales Market Share by Country (2019-2030)
 Figure 24. North America Biopharmaceuticals for Psoriasis Revenue Market Share by Country (2019-2030)
 Figure 25. United States Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Biopharmaceuticals for Psoriasis Sales Market Share by Country (2019-2030)
 Figure 28. Europe Biopharmaceuticals for Psoriasis Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Biopharmaceuticals for Psoriasis Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Biopharmaceuticals for Psoriasis Revenue Market Share by Region (2019-2030)
 Figure 36. China Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Biopharmaceuticals for Psoriasis Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Biopharmaceuticals for Psoriasis Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Biopharmaceuticals for Psoriasis Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Biopharmaceuticals for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Biopharmaceuticals for Psoriasis by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Biopharmaceuticals for Psoriasis by Type (2019-2030)
 Figure 55. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Biopharmaceuticals for Psoriasis by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Biopharmaceuticals for Psoriasis by Application (2019-2030)
 Figure 58. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Application (2019-2030)
 Figure 59. Biopharmaceuticals for Psoriasis Value Chain
 Figure 60. Biopharmaceuticals for Psoriasis Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Plaque Psoriasis Treatment Medications Market Research Report 2024
Global Psoriasis Therapeutics Market Insights Forecast to 2030
Global Psoriasis Biosimilar Market Research Report 2024
Global Chronic Plaque Psoriasis Therapeutics Market Research Report 2024
Global Anti inflammatory Skincare Ingredients Market Research Report 2025
Global Psoriatic Arthritis Therapeutics Drug Market Insights Forecast to 2030
Global Biologic Medications for Psoriasis Market Research Report 2024
Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Research Report 2024
Global Interleukin Inhibitors for Psoriasis Market Research Report 2024
Global Psoriasis Treatment Drugs Market Research Report 2025
Global Acne Therapeutics Market Research Report 2024
Global Psoriasis Biologics Drugs Market Research Report 2025
Psoriasis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acne Skin Medication Market Research Report 2024
Global Monoclonal Antibodies for Plaque Psoriasis Market Research Report 2024
Global Vitiligo Therapeutics Market Research Report 2024
Psoriatic Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025
Global Skin Disease Treatment Market Insights Forecast to 2030
Global IL 17 Inhibitors for Psoriasis Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions